Herantis Pharma Oyj
Herantis Pharma Oyj (HRPMF) Revenue
Annual & quarterly revenue history · segment & region breakdown
HRPMF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsHerantis Pharma Oyj trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Herantis Pharma Oyj receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Herantis Pharma Oyj reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Herantis Pharma Oyj's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
HRPMF revenue · 4 questionsHRPMF's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Herantis Pharma Oyj SEC filings · GAAP · Herantis Pharma Oyj SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026